Labaton Sucharow LLP and Motley Rice LLC Announce Proposed Class Action Settlement Involving Purchasers of the Publicly Traded Common Stock of Alexion Pharmaceuticals, Inc.
Retrieved on:
Tuesday, October 17, 2023
SUMMARY NOTICE OF PENDENCY OF CLASS ACTION, PROPOSED
Key Points:
- SUMMARY NOTICE OF PENDENCY OF CLASS ACTION, PROPOSED
To: All persons or entities who purchased or otherwise acquired the publicly traded common stock of Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") from January 30, 2014 to May 26, 2017, inclusive (the "Class Period"), and who were allegedly damaged thereby (the "Class"). - The Court may change the date of the Settlement Hearing, or hold it remotely, without providing another notice.
- You do NOT need to attend the Settlement Hearing in order to receive a distribution from the Net Settlement Fund.
- IF YOU ARE A MEMBER OF THE CLASS, YOUR RIGHTS WILL BE AFFECTED BY THE PROPOSED SETTLEMENT AND YOU MAY BE ENTITLED TO A MONETARY PAYMENT.